Intech Investment Management LLC Buys 46,748 Shares of Oscar Health, Inc. $OSCR

Key Points

• Intech Investment Management LLC increased its stake in Oscar Health by 50.3%, acquiring 46,748 additional shares, bringing its total to approximately 139,600 shares valued at $1.83 million.
• The stock of Oscar Health has experienced fluctuations, recently trading down 4.3% and has a twelve-month range between $11.20 and $23.79.
• Recent analyst ratings indicate a cautious outlook, with target prices dropped by firms like Piper Sandler and Barclays, and an average analyst rating of "Strong Sell" with a consensus price target of $12.07.

Intech Investment Management LLC boosted its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 50.3% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 139,600 shares of the company's stock after buying an additional 46,748 shares during the period. Intech Investment Management LLC owned approximately 0.06% of Oscar Health worth $1,830,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of OSCR. Victory Capital Management Inc. boosted its stake in shares of Oscar Health by 23.8% in the 1st quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock valued at $3,749,000 after purchasing an additional 54,938 shares in the last quarter. Toronto Dominion Bank bought a new position in Oscar Health during the 4th quarter worth approximately $1,008,000. Concurrent Investment Advisors LLC bought a new position in Oscar Health during the 1st quarter worth approximately $677,000. Nuveen LLC bought a new position in Oscar Health during the 1st quarter worth approximately $29,684,000. Finally, NewEdge Advisors LLC increased its stake in shares of Oscar Health by 89.7% in the 1st quarter. NewEdge Advisors LLC now owns 188,058 shares of the company's stock valued at $2,465,000 after acquiring an additional 88,946 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Trading Down 0.7%

Shares of OSCR stock traded down $0.14 on Friday, hitting $18.97. 17,336,897 shares of the company's stock traded hands, compared to its average volume of 16,224,456. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The stock has a market capitalization of $4.90 billion, a price-to-earnings ratio of -23.42 and a beta of 1.87. The company's fifty day simple moving average is $16.19 and its 200 day simple moving average is $15.27.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating the consensus estimate of ($0.90) by $0.01. The business had revenue of $2.86 billion for the quarter, compared to analysts' expectations of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The firm's revenue for the quarter was up 29.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.20 earnings per share. Equities analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently issued reports on OSCR. Raymond James Financial downgraded shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Barclays cut their price objective on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a report on Wednesday, July 23rd. Piper Sandler cut their price target on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a report on Thursday, August 14th. Baird R W downgraded shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Finally, Wall Street Zen downgraded shares of Oscar Health from a "hold" rating to a "sell" rating in a report on Saturday, August 9th. Four equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Strong Sell" and an average target price of $12.07.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.